|Articles|July 8, 2008

Thermage to buy Reliant for $87.5 million plus debt

New York - Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.

New York

- Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press.

Thermage is set to pay $25 million in cash and issue $23.6 million shares valued at $62.5 million. Thermage also agreed to assume $7 million in debt and provide $5 million of bridge financing to Reliant.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME